Carmila: Closing of the Acquisition of a Stake of 7% of Galimmo SCA from Capimmo
25 Julio 2024 - 12:29PM
Business Wire
Regulatory News:
Carmila (Paris:CARM) announces completion of the acquisition of
7% of the share capital of Galimmo SCA for a total consideration of
27 million euros, or 11.93 euros per share.
On June 28, 2024, Carmila granted to Capimmo1 a put option to
sell its entire 7% stake in Galimmo SCA, exercisable until July 30,
2024.
Carmila has therefore consolidated its position as Galimmo SCA’s
controlling shareholder by increasing its stake to 99.8% of the
share capital of Galimmo SCA.
As announced in the press release of July 1, 20242, Carmila will
file a simplified tender offer in the coming weeks, followed by a
squeeze-out, for the remaining shares in Galimmo SCA. The tender
offer price, which will not be lower than €11.93 and will comply
with squeeze-out provisions, will remain subject to the work of the
independent expert appointed by Galimmo SCA in accordance with
legal and regulatory provisions.
INVESTOR AGENDA
17 October 2024 (after market close): Financial
information for the third quarter 2024
ABOUT CARMILA
As the third-largest listed owner of commercial property in
Europe, Carmila was founded by Carrefour and large institutional
investors in order to enhance the value of shopping centres
adjoining Carrefour hypermarkets in France, Spain and Italy. At 31
December 2023, its portfolio was valued at €5.9 billion and is made
up of 201 shopping centres, with leading positions in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”). Carmila has been a member of the SBF
120 since 20 June 2022.
IMPORTANT NOTICE
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Regulatory Information” section of Carmila’s Finance webpage:
https://www.carmila.com/en/finance/regulatory-information/
1 Capimmo, formerly Primonial Capimmo, is an entity managed by
Præmia REIM France 2
https://www.carmila.com/wp-content/uploads/2024/07/24_07_01-Potential-stake-increase-in-Galimmo-SCA-to-99.9.pdf
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725981841/en/
INVESTORS AND ANALYSTS Pierre-Yves Thirion - CFO
pierre_yves_thirion@carmila.com +33 6 47 21 60 49
PRESS Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024